MLC901
- Generic Name
- MLC901
MLC901 in Hypoxic-ischemic Brain Injury Patients; A Double-blind, Randomized Placebo-controlled Trial
Early Phase 1
Completed
- Conditions
- Hypoxic Ischaemic Encephalopathy Due to Cardiac Arrest
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-11-18
- Last Posted Date
- 2022-11-18
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Target Recruit Count
- 35
- Registration Number
- NCT05621590
- Locations
- 🇮🇷
Shahid Beheshti University of Medical Sciences, Shohada Hospital, Tehran, Iran, Islamic Republic of
The Alzheimer's Disease THErapy With NEuroaid (ATHENE) Study
- First Posted Date
- 2017-01-31
- Last Posted Date
- 2017-01-31
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 150
- Registration Number
- NCT03038035
- Locations
- 🇸🇬
National University Hospital, Sg, Singapore
NEURoaid II (MLC 901) Assessment in Cognitively Impaired Not Demented Subjects
- First Posted Date
- 2013-05-07
- Last Posted Date
- 2018-07-27
- Lead Sponsor
- National University Hospital, Singapore
- Target Recruit Count
- 103
- Registration Number
- NCT01847924
- Locations
- 🇵ðŸ‡
University of Santo Tomas Hospital, Manila City, Metro Manila, Philippines
🇸🇬Singapore General Hospital, Singapore, Singapore
🇸🇬National Neuroscience Institute, Singapore, Singapore
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath